The therapeutic potential of TNF-alpha antagonists for skin psoriasis comorbidities. - Wikidata - awgldk - TriplyDB

The therapeutic potential of TNF-alpha antagonists for skin psoriasis comorbidities.

The therapeutic potential of TNF-alpha antagonists for skin psoriasis comorbidities.

http://www.wikidata.org/entity/Q37766229

about

Ustekinumab in psoriasis immunopathology with emphasis on the Th17-IL23 axis: a primer Topical delivery of anti-TNFα siRNA and capsaicin via novel lipid-polymer hybrid nanoparticles efficiently inhibits skin inflammation in vivo.Economic burden of comorbidities in psoriasis patients in the United States: results from a retrospective U.S. database.Patient considerations and targeted therapies in the management of psoriasis in Chinese patients: role of ustekinumab.Ustekinumab biotherapy and real-time psoriasis capacitance mapping: a pilot study.Challenging regional psoriasis and ustekinumab biotherapy: impact of the patterns of disease Focus on skin cancer association and progression under TNF antagonist therapy.Adalimumab in the treatment of plaque-type psoriasis and psoriatic arthritis.Biological therapies for psoriasis.Tumour necrosis factor inhibitors in the treatment of psoriatic arthritis: a view on effectiveness, clinical practice and toxicity.Management of cutaneous disorders related to inflammatory bowel disease.

P2860

Q24596756-32564E9C-33DE-43EE-A0D6-609E08B23317 Q30432272-6C909527-01E4-42D2-AC58-41CCEB87D536 Q33651728-C8431D3E-53E8-4F20-B6FB-BA880567E3CD Q33800651-144E72F2-88EE-4CEB-AF4D-86EC7EB96BD6 Q35878423-4681A9C9-B6D1-472C-A2F0-BB76A6744D0B Q36184265-AA353C8B-24F1-4A32-8BCA-246FA31F2EC0 Q37901473-5B074361-ACE9-472E-A145-DF82A05675C0 Q38127746-BDFE6EE6-57A2-41B5-B8A2-E02F6983A176 Q38155648-89462058-18FC-4FCD-9320-473C8CAA085B Q38264660-148A5BEA-89CB-4485-B601-BD0C15B0D1D5 Q42406766-5AD9EE40-E2F1-4135-9DF3-51AF47987FBC

P2860

The therapeutic potential of TNF-alpha antagonists for skin psoriasis comorbidities.

http://www.wikidata.org/entity/Q37766229

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on August 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

The therapeutic potential of TNF-alpha antagonists for skin psoriasis comorbidities.

@en

The therapeutic potential of TNF-alpha antagonists for skin psoriasis comorbidities.

@nl

type

label

The therapeutic potential of TNF-alpha antagonists for skin psoriasis comorbidities.

@en

The therapeutic potential of TNF-alpha antagonists for skin psoriasis comorbidities.

@nl

prefLabel

The therapeutic potential of TNF-alpha antagonists for skin psoriasis comorbidities.

@en

The therapeutic potential of TNF-alpha antagonists for skin psoriasis comorbidities.

@nl

P1433

Q37766229-67E414B6-AB77-41CC-9813-D4E27A42F9D9

P1476

Q37766229-083DDEB0-A113-4A36-958D-4EC6D59F598D

P2093

Q37766229-0C1C2EEE-2785-4EFB-AC87-51638C2B923A

Q37766229-36FB2BEF-85D3-492C-A8FB-B5C03B71EE3B

Q37766229-61B69EB4-2482-4685-AA96-B4DB0DB771A7

Q37766229-7A148E58-EF94-4FD8-8BC9-7D4CF295CDDB

Q37766229-F2CCE8ED-7657-4AB0-A698-C9A6AC610E59

P2860

Q37766229-01C01374-DDFE-4EDE-8AFA-11E61F24D0C7

Q37766229-0224E1E1-68DD-4738-A99B-AA869B14DD80

Q37766229-02AF36CD-3B00-4A4D-925A-1731EA44F6E1

Q37766229-08066FB7-36EB-40E8-8EEC-3899EC55379E

Q37766229-0ECE5B79-8D07-4810-967F-D3B410865FFE

Q37766229-0F56B380-73E5-4548-9F4F-7C104CBF66D2

Q37766229-13977C9C-F314-4120-976B-F525FAB6B606

Q37766229-14F503A2-BB10-4CEB-B8DD-09E5D224B3A9

Q37766229-18ED1E8D-CADA-4518-8F46-7CE3996D1A05

Q37766229-196E31C5-EE19-4C2B-9A2D-8A9C457814C2

P304

Q37766229-FA661C15-2B09-4033-A62F-AB5E175539B1

P31

Q37766229-E030F487-D744-43B0-A317-8414C439F2BF

P356

Q37766229-C4596F16-1829-4890-9031-5FB7B4C8CE19

P407

Q37766229-69E44FFA-F5FB-47CB-95B3-09F72AB5E7E8

P433

Q37766229-F8D5A667-57B7-4A49-A64E-DFECDCB6C9D5

P478

Q37766229-37CFCE60-355D-444D-B356-B7B4EC678613

P577

Q37766229-A85FD213-CC19-4C31-8F7E-991F5328304C

P698

Q37766229-A2A60B1A-962C-4596-ABF1-A8BEC9EFA545

P921

Q37766229-220853F5-5B75-4982-B65E-B48513FEA8F8

P356

14712598.2010.500283

P1433

Expert Opinion on Biological Therapy

P1476

The therapeutic potential of TNF-alpha antagonists for skin psoriasis comorbidities.

@en

P2093

Claudine Piérard-Franchimont

http://www.w3.org/2001/XMLSchema#string

Grégory Szepetiuk

http://www.w3.org/2001/XMLSchema#string

Gérald E Piérard

http://www.w3.org/2001/XMLSchema#string

Pascale Quatresooz

http://www.w3.org/2001/XMLSchema#string

Philippe Paquet

http://www.w3.org/2001/XMLSchema#string

P2860

The biological functions of T helper 17 cell effector cytokines in inflammation

The intriguing biology of the tumour necrosis factor/tumour necrosis factor receptor superfamily: players, rules and the games

Comparison of ustekinumab and etanercept for moderate-to-severe psoriasis

A genome-wide association study identifies IL23R as an inflammatory bowel disease gene

Altered bone remodeling in psoriatic arthritis

Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

Connections between psoriasis and Crohn's disease.

Quality of life and prevalence of arthritis reported by 5,795 members of the Nordic Psoriasis Associations. Data from the Nordic Quality of Life Study.

Adalimumab for long-term treatment of psoriatic arthritis: 2-year data from the Adalimumab Effectiveness in Psoriatic Arthritis Trial (ADEPT)

P304

1197-1208

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14712598.2010.500283

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P577

2010-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20560729

http://www.w3.org/2001/XMLSchema#string

P921